Jedynak Monika, Siemiatkowski Andrzej
Klinika Anestezjologii i Intensywnej Terapii Akademii Medycznej w Białymstoku.
Pol Merkur Lekarski. 2002 Sep;13(75):238-41.
Despite new generations of antibiotics and great improvement in the fields of rescue and modern intensive care medicine, sepsis remains one of the most frequent causes of complications and death in severely injured patients. Shock, bacterial colonization, invasive methods of treatment and immune mechanisms are reported to be responsible for the increased susceptibility of patients to sepsis after trauma. Posttraumatic immune abnormalities consist of two mechanistic entities: inappropriately hyperactive inflammatory processes and profound depression of cell-mediated immune function. Monocytes/macrophages carry out the fundamental protective functions of ingesting and killing invading microorganisms. Macrophages play a central role in the immune response by presenting antigens to lymphocytes, modulating T cell functions and by secreting a large number of inflammatory mediators. Macrophage-derived cytokines play key roles in the amplification of both humoral and cell-mediated immune responses. Depression of macrophage function appears to have serious deleterious effects in critically injured patients and has been associated with increased mortality. Phagocytosis, oxidative burst activity and cytokine secretion are impaired in macrophages early after traumatic injury. However, a widely accepted clinical treatment for post-injury immunosuppression does not currently exist. As our understanding of the pathogenesis of injury-induced immunosuppression progresses, our treatment approaches will likely improve.
尽管新一代抗生素不断涌现,急救和现代重症监护医学领域也有了很大进步,但脓毒症仍是重伤患者并发症和死亡的最常见原因之一。据报道,休克、细菌定植、侵入性治疗方法和免疫机制是创伤后患者易患脓毒症的原因。创伤后免疫异常由两个机制实体组成:炎症过程过度活跃且不适当,以及细胞介导的免疫功能严重抑制。单核细胞/巨噬细胞执行摄取和杀死入侵微生物的基本保护功能。巨噬细胞通过向淋巴细胞呈递抗原、调节T细胞功能以及分泌大量炎症介质,在免疫反应中发挥核心作用。巨噬细胞衍生的细胞因子在体液免疫和细胞介导免疫反应的放大中起关键作用。巨噬细胞功能的抑制在重症受伤患者中似乎具有严重的有害影响,并与死亡率增加有关。创伤后早期,巨噬细胞的吞噬作用、氧化爆发活性和细胞因子分泌均受损。然而,目前尚无一种被广泛接受的针对损伤后免疫抑制的临床治疗方法。随着我们对损伤诱导免疫抑制发病机制的理解不断深入,我们的治疗方法可能会得到改善。